发明授权
- 专利标题: Quinazolinone derivatives as ALDH-2 inhibitors
- 专利标题(中): 喹唑啉酮衍生物作为ALDH-2抑制剂
-
申请号: US12062431申请日: 2008-04-03
-
公开(公告)号: US07951813B2公开(公告)日: 2011-05-31
- 发明人: Matthew Abelman , Michael Organ , Jeff Zablocki , Wing Ming Keung , Guoxin Tao
- 申请人: Matthew Abelman , Michael Organ , Jeff Zablocki , Wing Ming Keung , Guoxin Tao
- 申请人地址: US CA Foster City
- 专利权人: Gilead Sciences, Inc.
- 当前专利权人: Gilead Sciences, Inc.
- 当前专利权人地址: US CA Foster City
- 代理机构: Gilead Sciences, Inc.
- 代理商 Brian Lewis
- 主分类号: A61K31/517
- IPC分类号: A61K31/517
摘要:
Disclosed are novel quinazolinone derivatives of formula: wherein: R1 is optionally substituted phenyl or optionally substituted heteroaryl; R2 is 3-hydroxy, 4-hydroxy, 3-NHR4 or 4-NHR4, in which R4 is hydrogen, —C(O)R5, —C(O)NHR6, or —SO2R6; in which R5 is optionally substituted lower alkyl or optionally substituted lower alkoxy; and R6 is optionally substituted lower alkyl; R3 is hydrogen, lower alkyl, lower alkoxy, or halo; V is oxygen, sulfur, or —NH—; and W is lower alkylene of 1-3 carbon atoms, which are useful as ALDH-2 inhibitors for treating mammals for various disease states, such as treatment for cocaine dependency and alcohol dependency.
公开/授权文献
- US20080249116A1 QUINAZOLINONE DERIVATIVES AS ALDH-2 INHIBITORS 公开/授权日:2008-10-09
信息查询
IPC分类: